Anatomic Pathology Market
Anatomic Pathology Market Forecasts to 2032 – Global Analysis By Product (Instruments, Consumables, and Services), Technique, Application, End User and By Geography
According to Stratistics MRC, the Global Anatomic Pathology Market is accounted for $38.78 billion in 2025 and is expected to reach $84.14 billion by 2032 growing at a CAGR of 11.7% during the forecast period. Anatomic pathology is a medical specialty focused on diagnosing diseases by examining tissues, organs, and cells removed from the body. It involves techniques such as gross examination, microscopic analysis, and advanced lab testing to identify abnormalities, including tumors, infections, and structural changes. Anatomic pathologists play a crucial role in guiding clinical decisions by providing precise diagnostic information that supports patient management, treatment planning, and disease monitoring across various medical fields.
According to the World Health Organization (WHO), in 2022, there were an estimated 20 million new cancer cases and 9.7 million deaths worldwide.
Market Dynamics:
Driver:
Growing adoption of personalized medicine
As treatments become more tailored to individual patient profiles, clinicians rely heavily on precise tissue analysis to guide decision-making. Molecular pathology and biomarker-driven testing are expanding, enhancing the accuracy of therapeutic selections. Integration of digital pathology and AI-based tools is enabling faster and more detailed diagnostic insights. Healthcare providers are increasingly investing in specialized pathology services to support individualized treatment strategies. This shift toward precision care is expected to continue strengthening the market's long-term growth.
Restraint:
Shortage of skilled pathologists and technicians
Many healthcare facilities face delays due to high workloads and limited expert availability. The growing complexity of diagnostic procedures further increases the demand for specialized skill sets. Training programs are not expanding quickly enough to meet rising diagnostic volumes. As a result, turnaround times may lengthen, affecting clinical decision-making. This workforce gap continues to pose operational challenges for institutions worldwide.
Opportunity:
Rising demand for companion diagnostics (CDx)
Increasing adoption of targeted therapies is accelerating the need for companion diagnostics in anatomic pathology. These tests help determine the suitability of specific drugs based on individual patient biomarkers. Growth in oncology pipelines is further driving CDx integration into clinical workflows. Advancements in tissue profiling technologies are enhancing the accuracy of predictive testing. Regulatory approvals for CDx-linked treatments are expanding across global markets. This rising demand is opening significant opportunities for pathology providers and diagnostic developers.
Threat:
Threat of substitute products/techniques
Liquid biopsy methods are gaining attention due to their non-invasive nature and faster turnaround times. Advancements in imaging-based diagnostics are also challenging traditional tissue examination. Some healthcare providers may shift toward these substitutes to streamline diagnostics. Rapid technological innovations could further reduce reliance on conventional pathology approaches. This competitive environment may limit growth for providers who do not adapt to evolving trends.
Covid-19 Impact:
The COVID-19 pandemic disrupted laboratory workflows and slowed elective diagnostic procedures in many facilities. Pathology departments faced reduced case volumes and delays in routine testing. However, the crisis accelerated digital pathology adoption and remote diagnostic review models. Laboratories invested in automation and cloud-based systems to maintain service continuity. Post-pandemic strategies now emphasize stronger infrastructure, workforce flexibility, and technology-enabled diagnostics.
The services segment is expected to be the largest during the forecast period
The services segment is expected to account for the largest market share during the forecast period, driven by rising outsourcing of diagnostic testing to specialized pathology laboratories. Healthcare providers rely on these services for advanced molecular and histopathological analyses. Service providers offer comprehensive testing workflows without requiring hospitals to invest in costly equipment. Their capabilities in digital pathology and rapid reporting further drive demand.
The hospitals & ambulatory surgical centers (ASCs) segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the hospitals & ambulatory surgical centers (ASCs) segment is predicted to witness the highest growth rate, due to rising patient admissions and expanding surgical procedures are increasing the demand for onsite pathology support. Many facilities are adopting digital pathology platforms to speed up diagnostic decisions. Investments in modern laboratory infrastructure are helping hospitals reduce reliance on external diagnostic centers. Adoption of AI-enabled tools is improving workflow efficiency and accuracy.
Region with largest share:
During the forecast period, the North America region is expected to hold the largest market share, due to strong healthcare infrastructure and high diagnostic testing volumes support this dominance. The region benefits from early adoption of digital pathology and AI-driven diagnostic tools. Large investments in cancer research and biomarker development further strengthen market growth. Favorable reimbursement policies encourage widespread use of advanced pathology services.
Region with highest CAGR:
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, owing to expanding healthcare systems and rising awareness of early disease diagnosis are fueling demand. Countries such as China and India are investing heavily in modern laboratory technologies. Growing incidences of cancer are accelerating the adoption of advanced pathology services. Public and private sector collaborations are improving diagnostic accessibility in emerging markets.
Key players in the market
Some of the key players in Anatomic Pathology Market include Roche Dia, Becton, Di, Thermo Fi, Hologic In, Agilent Te, PerkinElm, Danaher Co, Abbott Lab, Sakura Fin, Merck KGa, BioGenex, Cardinal H, Quest Dia, Laborator, and NeoGeno.
Key Developments:
In September 2025, Roche announced that it has entered into a definitive merger agreement to acquire 89bio, Inc., a publicly listed clinical-stage biopharmaceutical company pioneering the development of innovative therapies for the treatment of liver and cardiometabolic diseases. 89bio’s pegozafermin is a FGF21 analog currently in late-stage development for MASH in moderate and severe fibrotic patients.
In April 2025, Thermo Fisher Scientific has introduced the Thermo Scientific™ Krios™ 5 Cryo-TEM. This next-generation, atomic-resolution platform leverages enhanced optics and AI-enabled automation to study molecular structures and interactions at a throughput and fidelity that was previously unattainable.
Products Covered:
• Instruments
• Consumables
• Services
Techniques Covered:
• Histology
• Coagulation Tests
• Immunohistochemistry (IHC)
• Serology & Immunology
• Molecular Pathology
• Blood Routine Examination
Applications Covered:
• Disease Diagnosis
• Drug Discovery & Development
• Other Applications
End Users Covered:
• Hospitals & Ambulatory Surgical Centers (ASCs)
• Clinical & Diagnostic Laboratories
• Research Institutes
• Blood Banks
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Anatomic Pathology Market, By Product
5.1 Introduction
5.2 Instruments
5.2.1 Microtomes
5.2.2 Stainers
5.2.3 Tissue Processing Systems
5.3 Consumables
5.3.1 Reagents
5.3.2 Slides & Cassettes
5.3.3 Kits
5.4 Services
5.4.1 Histopathology Services
5.4.2 Immunohistochemistry Services
5.4.3 Cytopathology Services
5.4.4 Digital Pathology Services
6 Global Anatomic Pathology Market, By Technique
6.1 Introduction
6.2 Histology
6.3 Coagulation Tests
6.4 Immunohistochemistry (IHC)
6.5 Serology & Immunology
6.6 Molecular Pathology
6.7 Blood Routine Examination
7 Global Anatomic Pathology Market, By Application
7.1 Introduction
7.2 Disease Diagnosis
7.2.1 Oncology
7.2.2 Infectious Diseases
7.2.3 Chronic Conditions
7.3 Drug Discovery & Development
7.4 Other Applications
8 Global Anatomic Pathology Market, By End User
8.1 Introduction
8.2 Hospitals & Ambulatory Surgical Centers (ASCs)
8.3 Clinical & Diagnostic Laboratories
8.4 Research Institutes
8.5 Blood Banks
8.6 Other End Users
9 Global Anatomic Pathology Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 Roche Diagnostics
11.2 Becton, Dickinson and Company (BD)
11.3 Thermo Fisher Scientific
11.4 Hologic Inc.
11.5 Agilent Technologies
11.6 PerkinElmer
11.7 Danaher Corporation
11.8 Abbott Laboratories
11.9 Sakura Finetek Japan
11.10 Merck KGaA
11.11 BioGenex Laboratories
11.12 Cardinal Health
11.13 Quest Diagnostics
11.14 Laboratory Corporation of America Holdings
11.15 NeoGenomics Laboratories
List of Tables
1 Global Anatomic Pathology Market Outlook, By Region (2024-2032) ($MN)
2 Global Anatomic Pathology Market Outlook, By Product (2024-2032) ($MN)
3 Global Anatomic Pathology Market Outlook, By Instruments (2024-2032) ($MN)
4 Global Anatomic Pathology Market Outlook, By Microtomes (2024-2032) ($MN)
5 Global Anatomic Pathology Market Outlook, By Stainers (2024-2032) ($MN)
6 Global Anatomic Pathology Market Outlook, By Tissue Processing Systems (2024-2032) ($MN)
7 Global Anatomic Pathology Market Outlook, By Consumables (2024-2032) ($MN)
8 Global Anatomic Pathology Market Outlook, By Reagents (2024-2032) ($MN)
9 Global Anatomic Pathology Market Outlook, By Slides & Cassettes (2024-2032) ($MN)
10 Global Anatomic Pathology Market Outlook, By Kits (2024-2032) ($MN)
11 Global Anatomic Pathology Market Outlook, By Services (2024-2032) ($MN)
12 Global Anatomic Pathology Market Outlook, By Histopathology Services (2024-2032) ($MN)
13 Global Anatomic Pathology Market Outlook, By Immunohistochemistry Services (2024-2032) ($MN)
14 Global Anatomic Pathology Market Outlook, By Cytopathology Services (2024-2032) ($MN)
15 Global Anatomic Pathology Market Outlook, By Digital Pathology Services (2024-2032) ($MN)
16 Global Anatomic Pathology Market Outlook, By Technique (2024-2032) ($MN)
17 Global Anatomic Pathology Market Outlook, By Histology (2024-2032) ($MN)
18 Global Anatomic Pathology Market Outlook, By Coagulation Tests (2024-2032) ($MN)
19 Global Anatomic Pathology Market Outlook, By Immunohistochemistry (IHC) (2024-2032) ($MN)
20 Global Anatomic Pathology Market Outlook, By Serology & Immunology (2024-2032) ($MN)
21 Global Anatomic Pathology Market Outlook, By Molecular Pathology (2024-2032) ($MN)
22 Global Anatomic Pathology Market Outlook, By Blood Routine Examination (2024-2032) ($MN)
23 Global Anatomic Pathology Market Outlook, By Application (2024-2032) ($MN)
24 Global Anatomic Pathology Market Outlook, By Disease Diagnosis (2024-2032) ($MN)
25 Global Anatomic Pathology Market Outlook, By Oncology (2024-2032) ($MN)
26 Global Anatomic Pathology Market Outlook, By Infectious Diseases (2024-2032) ($MN)
27 Global Anatomic Pathology Market Outlook, By Chronic Conditions (2024-2032) ($MN)
28 Global Anatomic Pathology Market Outlook, By Drug Discovery & Development (2024-2032) ($MN)
29 Global Anatomic Pathology Market Outlook, By Other Applications (2024-2032) ($MN)
30 Global Anatomic Pathology Market Outlook, By End User (2024-2032) ($MN)
31 Global Anatomic Pathology Market Outlook, By Hospitals & Ambulatory Surgical Centers (ASCs) (2024-2032) ($MN)
32 Global Anatomic Pathology Market Outlook, By Clinical & Diagnostic Laboratories (2024-2032) ($MN)
33 Global Anatomic Pathology Market Outlook, By Research Institutes (2024-2032) ($MN)
34 Global Anatomic Pathology Market Outlook, By Blood Banks (2024-2032) ($MN)
35 Global Anatomic Pathology Market Outlook, By Other End Users (2024-2032) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We offer complimentary customization of up to 15% with every purchase. To share your customization requirements, feel free to email us at info@strategymrc.com or call us on +1-301-202-5929. .
Please Note: Customization within the 15% threshold is entirely free of charge. If your request exceeds this limit, we will conduct a feasibility assessment. Following that, a detailed quote and timeline will be provided.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
